Key result
Patients with MINOCA had a lower risk of 1-year all-cause mortality compared to patients with MI-CAD.
Why the study?
Debate remains regarding differences in mortality prevalence and acute event occurrence between patients with MINOCA and those with MI-CAD.
Does MINOCA reduce 1-year all-cause mortality and readmissions compared to MI-CAD in patients admitted for ACS?
Cohort (n=1,077)
No
Does MINOCA reduce 1-year all-cause mortality and readmissions compared to MI-CAD in patients admitted for ACS?
Patients with MINOCA have a more favorable short- and long-term prognosis, with significantly lower rates of 1-year mortality and hospital readmission for ACS or acute heart failure, compared to patients with MI-CAD.
Answers are grounded in this paper and cite their sources.
MINOCA associated with lower 1-year mortality than MI-CAD; leaves open whether this informs prognosis or requires prospective validation.
Introduction: The debate remains open as to the difference in prevalence of mortality and occurrence of acute events in patients with Myocardial infarction with non-obstructive coronary arteries (MINOCA) and others with Myocardial infarction with coronary arteries disease (MI-CAD). Methods: We conducted a 2-year retrospective study for patients admitted for Acute coronary syndrome (ACS) to analyze the clinical and prognostic characteristics of patients with MINOCA versus MI-CAD. We defined 1-year all-cause mortality as the primary outcome, and the secondary outcome as a composite of 1-year readmission for myocardial infarction or acute heart failure (AHF). Results: Our study included 1077 patients, 95.3% with MI-CAD and 4.7% with MINOCA. At admission, 71.1% patient were diagnosed STEMI and 28.9% with NSTEMI. The difference between the 2 groups was found on age ( P < .001), hypertension, diabetes with consecutive P-values of .007 and .001, as well as Ejection fraction ( P < .001). For the outcomes studied, the difference was significant between the 2 groups for all events, and MINOCA patients had a better prognosis than MI-CAD patients, with adjusted hazard ratios (HR) for 1-year mortality (HR = 0.601 P = .004), for readmission for ACS (HR = 0.662; P = .002) and for readmission for AHF (HR = 0.539; P = .019). Conclusion: Despite the ambiguity in the genesis of MINOCA, the short- and long-term prognosis of these patients remains generally favorable.
No takes yet. Share an insight, caveat, or question.
Bouchlarhem et al. (2024) conducted a cohort in Acute coronary syndrome (ACS) (n=1,077). Myocardial infarction with non-obstructive coronary arteries (MINOCA) vs. Myocardial infarction with coronary arteries disease (MI-CAD) was evaluated on 1-year all-cause mortality (HR 0.601, 95% CI 0.281-0.853, p=0.004). Patients with MINOCA had a lower risk of 1-year all-cause mortality compared to patients with MI-CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: